Inventor · disambiguated record
John Somberg
Also filed as: SOMBERG JOHN · SOMBERG JOHN C · SOMBERG JOHN CHARIN
23 granted patents·23 pending applications·87 citations·filing 1992–2025
94Inventor score
Files withAltaThera Pharmaceuticals LLC13SOMBERG JOHN C6ACAD PHARMACEUTICALS INC5ACADEMIC PHARM INC5SOMBERG JOHN CHARIN4
Top patents by PatentIndex Score
46 records- 0195US11731938B2Ultra short acting anti-arrhythmic agentsACAD PHARMACEUTICALS INC·Filed 2021·Granted Aug 22, 2023·2 cites·21 claims
- 0295US11344518B2Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frameAltaThera Pharmaceuticals LLC·Filed 2020·Granted May 31, 2022·6 cites·11 claims
- 0395US11286235B2Ultra short acting anti-arrhythmic agentsACAD PHARMACEUTICALS INCORPORATED·Filed 2020·Granted Mar 29, 2022·9 cites·24 claims
- 0495US10793519B2Ultra short acting anti-arrhythmic agentsACAD PHARMACEUTICALS INCORPORATED·Filed 2019·Granted Oct 6, 2020·10 cites·24 claims
- 0593US10512620B1Method of initiating and escalating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2018·Granted Dec 24, 2019·9 cites·20 claims
- 0690US11364213B2Method of initiating or escalating dofetilide dose and formulations thereforACAD PHARMACEUTICALS INC·Filed 2019·Granted Jun 21, 2022·4 cites·20 claims
- 0789US11696902B2Method of initiating and escalating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2019·Granted Jul 11, 2023·4 cites·5 claims
- 0888US11957648B2Method of initiating or escalating dofetilide dose and formulations thereforACAD PHARMACEUTICALS INC·Filed 2021·Granted Apr 16, 2024·1 cites·9 claims
- 0988US8481600B2Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral administration for the treatment of cardiovascular and other disease statesSOMBERG JOHN CHARIN·Filed 2009·Granted Jul 9, 2013·9 cites·7 claims
- 1080US12258309B2Ultra short acting anti-arrhythmic agentsACAD PHARMACEUTICALS INC·Filed 2023·Granted Mar 25, 2025·0 cites·12 claims
- 1179US7923447B2Parenteral solutions containing metolazoneACADEMIC PHARM INC·Filed 2008·Granted Apr 12, 2011·3 cites·17 claims
- 1278US2024156758A1Method of initiating and escalating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2024·Application pending·0 cites
- 1377US9427398B2Parenteral solutions containing metolazoneACAD PHARMACEUTICALS INCORPORATED·Filed 2012·Granted Aug 30, 2016·1 cites·18 claims
- 1475US12403109B2Sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2022·Granted Sep 2, 2025·0 cites·7 claims
- 1574US12390431B2Method of escalating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2019·Granted Aug 19, 2025·0 cites·11 claims
- 1674US2022339130A1Method of initiating and escalating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2022·Application pending·0 cites
- 1773US2024423935A1Method of initiating or escalating dofetilide dose and formulations thereforHYLORIS DEV S A·Filed 2024·Application pending·0 cites
- 1870US2023293455A1Method of initiating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2023·Application pending·0 cites
- 1969US6844355B2Optically active isomers of quinine and quinidine and their respective biological actionACADEMIC PHARM INC·Filed 2000·Granted Jan 18, 2005·5 cites·20 claims
- 2069US2022142954A1Method of initiating and escalating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2022·Application pending·0 cites
- 2168US2025177413A1Short acting esters of ivabradineACAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2264US2025152530A1Sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2025·Application pending·0 cites
- 2363US2020253903A1Method of initiating and escalating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2020·Application pending·0 cites
- 2462US8664267B2Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide)SOMBERG JOHN CHARIN·Filed 2007·Granted Mar 4, 2014·0 cites·18 claims
- 2561US2025350689A1Intravenous dofetilide and uses thereofHYLORIS DEV SA·Filed 2025·Application pending·0 cites
- 2660US12343320B2Intraveneous dofetilide to reduce the risk of developing AF/AFL post coronary bypass surgeryHYLORIS DEV SA·Filed 2023·Granted Jul 1, 2025·0 cites·23 claims
- 2760US2024285558A1Intraveneous dofetilide to terminate arrhythmic storm following implantation of a cardiac defibrilatorHYLORIS DEV SA·Filed 2023·Application pending·0 cites
- 2859US8513278B2Parenteral dextrose formulation of clopidogrelACADEMIC PHARM INC·Filed 2012·Granted Aug 20, 2013·0 cites·20 claims
- 2955US2010010096A1Methadone chiral isolate as an improved pharmaceuticalSOMBERG JOHN CHARIN·Filed 2009·Application pending·0 cites
- 3055US2009060894A1Treatment to aid in the metabolism of alcoholSOMBERG JOHN CHARIN·Filed 2007·Application pending·0 cites
- 3154US2021283049A1Intravenous sotalol hydrochloride loading and maintenance for cardiac surgery patientsAltaThera Pharmaceuticals LLC·Filed 2021·Application pending·0 cites
- 3252US5234949AParenteral solutions containing amiodarone in acetate buffer solutionACADEMIC PHARM INC·Filed 1992·Granted Aug 10, 1993·17 cites·2 claims
- 3351US2012077829A1Parenteral solutions containing metolazoneSOMBERG JOHN C·Filed 2011·Application pending·0 cites
- 3450US2006074032A1Synthesis and separation of optically active isomers of erythromycin and their biological actionsACADEMIC PHARM INC·Filed 2005·Application pending·0 cites
- 3550US2010029577A1Chiral separation, characterization and biological action of optically active isomers of digoxinSOMBERG JOHN·Filed 2008·Application pending·0 cites
- 3649US2013217779A1Methadone chiral isolate as an improved pharmaceuticalSOMBERG JOHN C·Filed 2012·Application pending·0 cites
- 3747US2004067898A1Synthesis and separation of optically active isomers of erythromycin and their biological actionsFiled 2001·Application pending·0 cites
- 3843US2009325918A1Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological actionSOMBERG JOHN C·Filed 2008·Application pending·0 cites
- 3942US2025152529A1Method of escalating sotalol hydrochloride dosingAltaThera Pharmaceuticals LLC·Filed 2025·Application pending·0 cites
- 4041US5981514A(N-alkyl-N-hydroxymethylamino)alkoxybenzoylbenzofurans and the phosphate esters thereofFiled 1999·Granted Nov 9, 1999·2 cites·17 claims
- 4141US2013190621A1Thrombosis warning systemSOMBERG JOHN·Filed 2012·Application pending·0 cites
- 4240US2006069043A1Chiral separation, characterization and biological action of optically active isomers of digoxinSOMBERG JOHN C·Filed 2004·Application pending·0 cites
- 4339US8563574B2Parenteral formulation of clopidogrelSOMBERG JOHN C·Filed 2010·Granted Oct 22, 2013·0 cites·22 claims
- 4437US6030998AMethods for treating arrhythmia using acetate buffer solutions of amiodaroneACADEMIC PHARMACEUTICALS LP·Filed 1999·Granted Feb 29, 2000·4 cites·21 claims
- 4537US2006111369A1Synthesis, characterization and biological action of optically active isomers of floxacinsSOMBERG JOHN C·Filed 2004·Application pending·0 cites
- 4631US6103757AMethods for treating arrhythmia using acetate buffer solutions of amiodaroneACADEMIC PHARMACEUTICALS LP·Filed 1999·Granted Aug 15, 2000·1 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when John Somberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →